Teijin Limited and Versartis Enter Strategic Alliance for Commercialization of Somavaratan Long-Acting Growth Hormone in Japan Teijin’s regulatory and commercial infrastructure ideally suited to capitalize on somavaratan, which is positioned to be the first...
Edge Therapeutics Announces First Patient Treated in Phase 3 NEWTON 2 Study of EG-1962 in Adult Patients with Aneurysmal Subarachnoid Hemorrhage Pivotal, double-blind, placebo-controlled global study will compare EG-1962 to standard of care oral nimodipine BERKELEY...
Recent Comments